GlassScriptPhysician profile
Gordon L Grado
NPI 1225092745
$12,007.46
in general payments reported to CMS, 2019-2025
46 companies · $867 in 2025
The $867 reported for 2025 was more than what 82% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $937 · 2020: $641 · 2021: $1,756 · 2022: $587 · 2023: $2,026 · 2024: $5,193 · 2025: $867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,600 · Food and Beverage: $2,981 · Travel and Lodging: $1,322 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,600.00 |
| Food and Beverage | $2,981.30 |
| Travel and Lodging | $1,322.34 |
| Education | $183.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $3,860.40 | 2020-2025 | Optune, Optune Lua (Novottf-200t) |
| Reflexion Medical, INC. | $2,354.71 | 2023-2025 | Reflexion Medical Radiotherapy System |
| Isoray, INC | $1,264.54 | 2021-2023 | Brachytherapy Source |
| Blue Earth Diagnostics | $838.50 | 2019-2025 | Posluma |
| Boston Scientific Corporation | $425.59 | 2019-2020 | |
| Medtronic USA, INC. | $317.99 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $308.02 | 2021-2024 | Pylarify |
| Novartis Pharmaceuticals Corporation | $248.96 | 2019-2025 | |
| Janssen Biotech, INC. | $244.89 | 2019-2025 | Rybrevant, Erleada, Tecvayli |
| Lilly USA, LLC | $231.46 | 2021-2025 | Jaypirca, Verzenio |
| Accuray Incorporated | $184.94 | 2021-2025 | |
| Elekta, INC. | $163.90 | 2019 | |
| Merck Sharp & Dohme LLC | $157.10 | 2019-2025 | Keytruda, Keytruda Qlex |
| Tersera Therapeutics LLC | $147.18 | 2019-2021 | |
| Intuitive Surgical, INC. | $130.73 | 2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Grado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.